Change search criteria ↓

Search results

111 projects found matching your search criteria:

  1. 51. Dissecting of the novel mechanisms in multi-drug resistance associated with vault's proteins and translation initiation …

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: SONATA BIS 8, Panel: NZ7

  2. 52. Genetic features of Reed-Sternberg cells and their interplay with macrophages in classical Hodgkin lymphoma: identificat…

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: HARMONIA 8, Panel: NZ5

  3. 53. Role of sirtuin 2 (SIRT2) in the drug resistance of melanomas.

    Principal investigator: dr Marcin Marek Ratajewski

    Instytut Biologii Medycznej PAN

    Call: OPUS 9, Panel: NZ5

  4. 54. Abeta 4-x peptides as copper binding molecules resistant to chelating drugs, promoting the formation of amyloid oligomer…

    Principal investigator: prof. Wojciech Bal

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 8, Panel: ST5

  5. 55. Immunological biomarkers of drug resistant epilepsy and response to immunomodulatory therapy with ACTH in children

    Principal investigator: Magdalena Dorota Kaczorowska-Frontczak

    INSTYTUT - POMNIK - CENTRUM ZDROWIA DZIECKA

    Call: PRELUDIUM 6, Panel: NZ4

  6. 56. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ7

  7. 57. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C…

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

    Call: PRELUDIUM BIS 4, Panel: ST8

  8. 58. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro…

    Principal investigator: Krzysztof Nowicki

    Politechnika Warszawska, Wydział Chemiczny

    Call: PRELUDIUM 22, Panel: ST5

  9. 59. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 28, Panel: NZ7

  10. 60. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 25, Panel: NZ5

  11. 61. Plant bacterial endophytes as an important antibiotic-resistance dissemination vector

    Principal investigator: dr Magdalena Marta Zalewska

    Uniwersytet Warszawski, Wydział Biologii

    Call: SONATA 18, Panel: NZ9

  12. 62. Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

    Principal investigator: Magdalena Alicja Strachowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 21, Panel: NZ5

  13. 63. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized…

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  14. 64. Assessment of therapeutic value and usefulness of new generation antibiotics and their metabolites as resistance markers…

    Principal investigator: Katarzyna Joanna Pauter-Iwicka

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: PRELUDIUM 19, Panel: ST4

  15. 65. Determination of mechanisms and critical molecular partners controlling the multidrug resistance proteins (P-gp and BCRP…

    Principal investigator: dr hab. Marlena Godlewska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO, Studium Kliniczno-Dydaktyczne

    Call: OPUS 15, Panel: NZ3

  16. 66. CBR1-dependent metabolism and ABCB1-dependent effux of doxorubicin - search for a novel mechanism of reversing resistanc…

    Principal investigator: Kamil Tomasz Piska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 13, Panel: NZ7

  17. 67. Studies of the role of toxin-antitoxin systems in antibiotics resistance in staphylococci.

    Principal investigator: dr hab. Benedykt Władyka

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 13, Panel: NZ6

  18. 68. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

    Principal investigator: dr Anna Woziwodzka

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: SONATA 11, Panel: NZ7

  19. 69. Genotypes, antimicrobial resistance and virulence factors of staphylococci isolated from pet cats

    Principal investigator: Karolina Karolina Bierowiec

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

    Call: PRELUDIUM 11, Panel: NZ7

  20. 70. Endocytosis-stimulating antibodies against multidrug transporters as drug carriers

    Principal investigator: dr hab. Łukasz Pułaski

    Instytut Biologii Medycznej PAN

    Call: OPUS 10, Panel: NZ7

  21. 71. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  22. 72. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h…

    Principal investigator: Zofia Felicja Bielecka

    Wojskowy Instytut Medyczny

    Call: PRELUDIUM 9, Panel: NZ5

  23. 73. Role of reactive oxygen species in BCR/ABL+ cells resistance to IM

    Principal investigator: Sylwester Głowacki

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 3, Panel: NZ3

  24. 74. Role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to imatinib

    Principal investigator: prof. Janusz Błasiak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 2, Panel: NZ2

  25. 75. New drug carriers in targeted anticancer therapy

    Principal investigator: prof. Artur Piotr Terzyk

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: OPUS 1, Panel: ST5

  26. 76. Efficiency of photodynamic reaction enhanced electroporation in human cancer cells sensitive and resistant to chemothera…

    Principal investigator: dr Julita Kulbacka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: SONATA 1, Panel: NZ4

  27. 77. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

    Principal investigator: dr Joanna Dagmara Fedorowicz

    Gdański Uniwersytet Medyczny

    Call: SONATA 20, Panel: NZ7

  28. 78. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of…

    Principal investigator: dr hab. Carlo Vascotto

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: OPUS 22, Panel: NZ5

  29. 79. Make an old drug great again – isoniazid/rifamycin-boron clusters conjugates – synthesis and antitubercular activity.

    Principal investigator: dr hab. Agnieszka Bogusława Olejniczak

    Instytut Biologii Medycznej PAN

    Call: OPUS 20, Panel: NZ7

  30. 80. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 13, Panel: NZ7

  31. 81. The effect of reductive activation of antitumour anthracycline antibiotics and their synthetic analogues on restoring cy…

    Principal investigator: prof. Jolanta Tarasiuk

    Uniwersytet Szczeciński, Wydział Biologii

    Call: OPUS 3, Panel: NZ3

  32. 82. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: SONATA BIS 14, Panel: ST11

  33. 83. Directed screening and evaluation of novel bactericidal compounds active againsttubercle bacilli and Mycobacterium absce…

    Principal investigator: prof. Jarosław Dziadek

    Instytut Biologii Medycznej PAN

    Call: OPUS 25, Panel: NZ7

  34. 84. Reserved antibiotics and critical priority pathogens in hospital wastewater as an indicator of sanitary-epidemiological …

    Principal investigator: prof. Ewa Korzeniewska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

    Call: OPUS 23, Panel: NZ7

  35. 85. Effect of the co-treatment of municipal wastewater and landfill leachate on the spread of ARGs in the environment

    Principal investigator: Małgorzata Czatzkowska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

    Call: PRELUDIUM 19, Panel: NZ9

  36. 86. RNA biology at the phage-bacteria interface

    Principal investigator: dr Ewelina Magdalena Małecka-Grajek

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 29, Panel: NZ1

  37. 87. Fungal membrane modeling for selected antifungal compounds interactions

    Principal investigator: dr Dominik Drabik

    Politechnika Wrocławska

    Call: SONATA 20, Panel: NZ9

  38. 88. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap…

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ3

  39. 89. Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

    Principal investigator: dr Piotr Wilk

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  40. 90. Exploiting the weakness of lymphoma: spectroscopic identification of biomarkers for lymphoma metabolism and inducing its…

    Principal investigator: Patrycja Dawiec

    Uniwersytet Jagielloński

    Call: PRELUDIUM 23, Panel: ST4

  41. 91. Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

    Principal investigator: Piotr Maciej Chyży

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: PRELUDIUM 22, Panel: NZ1

  42. 92. Relationship between ATPase activity stimulation and transport - the case of selective Medicago truncatula ABCG transpor…

    Principal investigator: dr Konrad Mateusz Pakuła

    Instytut Chemii Bioorganicznej PAN

    Call: PRELUDIUM 20, Panel: NZ1

  43. 93. Propolis and polyphenols derived from this product as potential antifungal agents

    Principal investigator: dr hab. Piotr Szweda

    Politechnika Gdańska

    Call: OPUS 20, Panel: NZ7

  44. 94. The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

    Principal investigator: dr Magdalena - Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATA 16, Panel: NZ5

  45. 95. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  46. 96. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Principal investigator: dr hab. Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 18, Panel: NZ5

  47. 97. The use of evolutionary patterns in the optimization of chemotherapy of tuberculosis

    Principal investigator: dr Alina Ewa Minias

    Instytut Biologii Medycznej PAN

    Call: SONATA BIS 9, Panel: NZ6

  48. 98. The use of olaparib and ATR / CHK1 kinase inhibitors as a targeted anti-cancer therapy based on synthetic lethality

    Principal investigator: dr hab. Aneta Katarzyna Rogalska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: SONATA BIS 9, Panel: NZ7

  49. 99. Determination of the mechanisms and possibility of central nervous system regeneration using mesenchymal stem cells and …

    Principal investigator: prof. Marcin Marek Majka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

    Call: OPUS 16, Panel: NZ3

  50. 100. Evaluation of anticancer properties and molecular mechanisms of action of new hybrid molecules containing uracil skeleto…

    Principal investigator: dr Angelika Agata Długosz-Pokorska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 13, Panel: NZ3

Graphic design and implementation: Jakub Piotrowski